S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism
Min Yang(Shandong University), Bo Chu(Shandong University), Lihui Han(Shandong University), Yeping Cheng(Shandong University), Caiyu Sun(Shandong University), Weiwei Cui(Qilu Hospital of Shandong University), Gaozhong Xiong(Shandong University), Xiuling Cui(Shandong University), Xiaoting Lv(Shandong University), Wei Ma(Ningbo Science and Technology Bureau), Haocheng Xuan(Shandong University)
Cited by 35
Related Papers
Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
|Laboratory Investigation|2013|297
Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis
|Cell Death and Differentiation|2021|226
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition
|Nature Cell Biology|2024|198
Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
|Advanced Science|2023|151